- Next Generation Monoclonal DevelopmentNext Generation Monoclonal Development
Generation Monoclonal Development
Yurogen Biosystems is located in the Greater Boston area, a world-class biotech and biopharma hub. We are dedicated to producing premium antibodies and antibody-based products to meet the broad needs of our clients. Our innovative platform --- SMabTM Platform that can efficiently develop monoclonal antibodies from a variety of host animals, especially rabbit. Our state-of-the-art monoclonal antibody screening platform can significantly shorten the screening process and yield high-affinity monoclonal antibodies with broad diversity.